JNJ vs KO: Which Is the Better Buy?
Side-by-side comparison of Johnson & Johnson and The Coca-Cola Company — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-05-04.
Johnson & Johnson · Healthcare
$230.69
+14.0% upside to fair value
Grade C
High Quality
VS
The Coca-Cola Company · Consumer Defensive
$78.19
-7.8% upside to fair value
Grade D
High Quality
QuantHub Verdict
JNJ has more upside to fair value
(+14.0%).
KO trades at a lower forward P/E
(24.6x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
JNJ |
KO |
| Current Price |
$230.69 |
$78.19 |
| Fair Value Estimate |
$263.05 |
$72.12 |
| Upside to Fair Value |
+14.0%
|
-7.8%
|
| Market Cap |
$555.9B |
$336.5B |
| Forward P/E |
26.8x
|
24.6x
|
| EV / EBITDA |
18.5x
|
19.9x
|
| Price / Sales |
5.8x
|
6.8x
|
| Price / FCF |
28.2x
|
26.8x
|
| Revenue Growth YoY |
+9.9%
|
+12.1%
|
| Gross Margin |
69.1%
|
61.7%
|
| Operating Margin |
26.9%
|
29.3%
|
| Return on Equity |
26.5%
|
43.6%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
3.54%
|
3.73%
|
| Analyst Consensus |
Buy
|
Strong Buy
|
Investment Thesis
Johnson & Johnson is a leading healthcare company focused on pharmaceuticals and medical devices following its consumer health spin-off. The business quality is high due to its durable competitive moat, diversified portfolio, and strong management with deep institutional knowledge. Despite a 52.4% decline in earnings in the most recent quarter, revenue grew 9.9% year-over-year in the same period,…
The Coca-Cola Company is a leading global beverage company specializing in non-alcoholic drinks with a diversified portfolio including sparkling soft drinks, juices, water, coffee, and energy beverages. The business quality is high due to its durable brand moat, consistent earnings growth, and strong operational efficiency, reflected in a 43.6% return on equity and 12.1% revenue growth in the mos…
Accumulation Zones
| Metric |
JNJ |
KO |
| Zone Low |
$197.29 |
$54.09 |
| Zone High |
$223.59 |
$61.30 |
| In Buy Zone? |
No
|
No
|